(See also Overview of Immunodeficiency Disorders.)
Ataxia-telangiectasia is a primary immunodeficiency disorder. It is usually inherited as an autosomal (not sex-linked) recessive disorder. That is, two genes for the disorder, one from each parent, are required.
The increased susceptibility to infections in people with ataxia-telangiectasia results from malfunction of B cells and T cells (lymphocytes), which help the body defend itself against microorganisms and development of abnormal cells that can lead to cancer. Often, levels of certain types (classes) of antibodies (immunoglobulins)—IgA and IgE—are also low.
Ataxia-telangiectasia also causes abnormalities in the cerebellum (the part of the brain that coordinates the body’s movements), which are unrelated to the immunodeficiency disorder and which result in loss of coordination.
Incoordination (ataxia) usually develops when children begin to walk, but it may be delayed until age 4. Speech becomes slurred, and muscles progressively weaken, leading to severe disability. Intellectual disability may develop and progress.
Between the ages of 1 and 6 (but often not until age 4), capillaries in the skin and eyes become dilated and visible. The dilated capillaries (telangiectasia), called spider veins, are usually most obvious on the eyeballs, ears, and sides of the neck.
Ataxia-telangiectasia usually progresses to paralysis, dementia, and death, typically by age 30.
Doctors suspect ataxia-telangiectasia based on symptoms.
Blood tests to measure the levels of IgA and genetic tests can help confirm the diagnosis.
If doctors suspect endocrine disorders or cancers based on results of their examination, tests to check for these disorders are done.
To help prevent infections, doctors give people antibiotics and immune globulin (antibodies obtained from the blood of people with a normal immune system), which provides the missing immunoglobulins. Immune globulin may be injected into a vein (intravenously) once a month or under the skin (subcutaneously) once a week or once a month.
However, these drugs do not relieve the other problems.
The following is an English-language resource that may be useful. Please note that THE MANUAL is not responsible for the content of this resource.
Immune Deficiency Foundation: Ataxia-telangiectasia: General information on ataxia-telangiectasia, including information on diagnosis and treatment
Drugs Mentioned In This Article
|Generic Name||Select Brand Names|